AstraZeneca Sets Target to Bring in $80bn in Revenue by 2030
Assura plc Announces Year End Results to March 2024
GSK Announces Positive Results for Phase III Asthma Trials of Depemokimab
AstraZeneca plc Plans to Build $1.5bn Manufacturing Facility in Singapore
Land Securities Group plc Results for the Year Ended 31st March 2024
Renold plc Announces Renewed Partnership with British Cycling
Sequoia Economic Infrastructure NAV and Investment Update
